JeNaCell develops and manufactures high-purity biosynthetic cellulose produced by bacteria
JeNaCell develops and manufactures high-purity biosynthetic cellulose produced by bacteria. Its bioengineered material platform serves medical devices, wound care, implants, drug delivery, and professional skin care. The company uses automated commercial-scale production and was acquired by Evonik in 2021.